Impact on Patient of the Detection of Weakly Expressed RhD Antigens in Blood Donors

Overview

Journal Rev Bras Hematol Hemoter

Publisher Elsevier

Specialty Hematology

Date 2015 Sep 27

PMID 26408360

Citations 2

Authors

Helio Moraes-Souza

Vitor Mendonca Alves

Affiliations

Soon will be listed here.

Citing Articles

Prevalence of D variants in the Indian donor population.

Subramaniyan R Hematol Transfus Cell Ther. 2019; 41(2):190-193.

PMID: 31084770 PMC: 6517790. DOI: 10.1016/j.htct.2018.09.004.

Transfusion Medicine and Molecular Genetic Methods.

Saleh R, Zefarina Z, Che Mat N, Chambers G, Edinur H Int J Prev Med. 2018; 9:45.

PMID: 29899883 PMC: 5981227. DOI: 10.4103/ijpvm.IJPVM_232_16.

References

Nardozza L, Szulman A, Barreto J, Araujo Junior E, Moron A . [The molecular basis of RH system and its applications in obstetrics and transfusion medicine]. Rev Assoc Med Bras (1992). 2011; 56(6):724-8. DOI: 10.1590/s0104-42302010000600026. View

Polin H, Danzer M, Gaszner W, Broda D, St-Louis M, Proll J . Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria. Transfusion. 2009; 49(4):676-81. DOI: 10.1111/j.1537-2995.2008.02046.x. View

Sandler S, Flegel W, Westhoff C, Denomme G, Delaney M, Keller M . It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. Transfusion. 2014; 55(3):680-9. PMC: 4357540. DOI: 10.1111/trf.12941. View

Costa S, Martin F, Chiba A, Langhi Jr D, Chiattone C, Bordin J . RHD alleles and D antigen density among serologically D- C+ Brazilian blood donors. Transfus Med. 2013; 24(1):60-1. DOI: 10.1111/tme.12088. View

Flegel W . The genetics of the Rhesus blood group system. Blood Transfus. 2009; 5(2):50-7. PMC: 2535884. DOI: 10.2450/2007.0011-07. View

Lejon Crottet S, Haer-Wigman L, Gowland P, Fontana S, Niederhauser C, Hustinx H . Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA. Transfusion. 2013; 53(11 Suppl 2):3000-8. DOI: 10.1111/trf.12363. View

Gassner C, Doescher A, Dovc Drnovsek T, Rozman P, Eicher N, Legler T . Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion. 2005; 45(4):527-38. DOI: 10.1111/j.0041-1132.2004.04211.x. View

Orzinska A, Guz K, Polin H, Pelc-Klopotowska M, Bednarz J, Gielezynska A . RHD variants in Polish blood donors routinely typed as D-. Transfusion. 2013; 53(11 Suppl 2):2945-53. PMC: 5497842. DOI: 10.1111/trf.12230. View

Thakral B, Saluja K, Sharma R, Marwaha N . Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India. Hematology. 2008; 13(5):313-8. DOI: 10.1179/102453308X343419. View

10.

Van Sandt V, Gassner C, Emonds M, Legler T, Mahieu S, Kormoczi G . RHD variants in Flanders, Belgium. Transfusion. 2014; 55(6 Pt 2):1411-7. DOI: 10.1111/trf.12947. View

11.

Schmidt L, Castilho L, Vieira O, Sippert E, Gaspardi A, Martins M . Impact of a confirmatory RhD test on the correct serologic typing of blood donors. Rev Bras Hematol Hemoter. 2015; 37(5):302-5. PMC: 4685092. DOI: 10.1016/j.bjhh.2015.06.001. View

12.

Schonewille H, van de Watering L, Loomans D, Brand A . Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion. 2006; 46(2):250-6. DOI: 10.1111/j.1537-2995.2006.00708.x. View